New hope for pancreatic cancer patients struggling with weight loss

NCT ID NCT04098237

Summary

This study is testing whether adding a digestive enzyme supplement called Pancreaze to standard cancer care helps pancreatic cancer patients maintain their weight and improve their quality of life. The research focuses on patients who have lost significant weight and have trouble digesting food properly due to their cancer. Researchers will track if patients can stick with the enzyme treatment and measure changes in weight, nutrition, digestion, and daily activity over time.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Cedars-Sinai Medical Center

    Los Angeles, California, 90048, United States

Conditions

Explore the condition pages connected to this study.